DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis
DEA proposes new telemedicine prescribing rules that may impose additional burdens on hospice physicians and operations.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 3, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Hospice physicians and hospice operations. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmacy & Controlled Substances move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
Proposed rules may complicate the telemedicine prescribing process for controlled substances.
Who it affects
Hospice physicians and hospice operations.
What you must do
Review the proposed rules and assess their impact on current telemedicine practices.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- New Maine law recognizes pharmacists as health care providers - une.edu
- Florida pharmacists receive approval to provide COVID-19 vaccines - wusf.org
- Express Scripts Launches Court Fight on Arkansas Pharmacy Law - news.bloomberglaw.com
- Determination That PHENAPHEN WITH CODEINE NO. 3 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 30 Milligrams, and PHENAPHEN WITH CODEINE NO. 4 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 60 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Pharmacies may violate civil rights if they refuse meds linked to abortion, feds warn - NPR